INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
|
|
- Beryl Webb
- 5 years ago
- Views:
Transcription
1 INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report Centers for Medicare & Medicaid Services st Quarter Implant and event dates: June 23, 2006 to March 31, 2013 Prepared by: The Data Collection and Analysis Center University of Alabama at Birmingham For questions or comments contact: James K. Kirklin, MD at David C. Naftel, Ph.D at Susan L. Myers at Mary Lynne Clark at Stephen Craig Collum at Kathryn Hollifield at Ryan S. Cantor at Page 1 of 27
2 INTERMACS Quarterly Report Implants: June 23, 2006 to March 31, 2013 # HHSN C The Interagency Registry for Mechanically Assisted Circulatory Support is a North American registry established in 2005 for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. INTERMACS TM was established as a joint effort of the National Heart, Lung and Blood Institute (NHLBI), the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), clinicians, scientists and industry representatives in conjunction with Dr. James K. Kirklin and the University of Alabama at Birmingham. This quarterly report includes clinical information from 2254 patients 65 years old or older receiving primary prospective implants between June 23, 2006 and March 31, Table of Contents Exhibit 1: Hospital Activation and Patient Enrollment - Patients 65 Years Old and Older... 3 Exhibit 2: Participating Hospital Listing... 4 Exhibit 3: Patient Demographics by Implant Period - Patients 65 Years Old and Older... 8 Exhibit 4: Implants by Year by Device Strategy - Patients 65 Years Old and Older... 9 Exhibit 5: Implants per Year by Device Type - Patients 65 Years Old and Older Exhibit 6: Patient Profile at Time of Implant by Implant Period - Patients 65 Years Old and Older Exhibit 7: Device Strategy at Time of Implant by Implant Period - Patients 65 Years Old and Older Exhibit 8: Patient Profile by Device Strategy at Time of Implant - Patients 65 Years Old and Older Exhibit 9: Patient Status by Device Strategy at Implant - Patients 65 Years Old and Older Exhibit 10: Primary Cause of Death - Patients 65 Years Old and Older Exhibit 11: Kaplan-Meier Survival for INTERMACS OVERALL - Patients 65 Years Old and Older Exhibit 12: Kaplan-Meier Survival by Flow Type and Device - Patients 65 Years Old and Older Exhibit 13: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Implant Era - Patients 65 Years Old and Older Exhibit 14: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Pre-Implant Device Strategy - Patients 65 Years Old and Older Exhibit 15: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Pre-Implant Patient Profile - Patients 65 Years Old and Older Exhibit 16: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Device Type - Patients 65 Years Old and Older Exhibit 17: Competing Outcomes for Continuous Flow LVADs (without RVAD implant at time of LVAD operation) - Patients 65 Years Old and Older Exhibit 18: Competing Outcomes for Continuous Flow LVADs (with RVAD implant at time of LVAD operation) - Patients 65 Years Old and Older Exhibit 19: Adverse Event Rates for Patients Receiving a Primary Prospective Implant - Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) - Patients 65 Years Old and Older Exhibit 20: Compliance Page 2 of 27
3 Exhibit 1: Hospital Activation and Patient Enrollment - Patients 65 Years Old and Older Between June 23, 2006 and March 31, 2013, 153 hospitals participated in INTERMACS and, of these, 129 hospitals actively contributed information on a total of 2254 patients. Cumulative patient accrual and the number of participating hospitals over this time period are displayed below. Page 3 of 27
4 Exhibit 2: Participating Hospital Listing # HHSN C As of March 31, 2013 there were 153 hospitals participating in INTERMACS. HOSPITAL NAME CITY STATE ABBOTT NORTHWESTERN HOSPITAL MINNEAPOLIS MN ABINGTON MEMORIAL HOSPITAL ABINGTON PA ADVOCATE CHRIST MEDICAL CENTER OAK LAWN IL ALBANY MEDICAL CENTER ALBANY NY ALBERT EINSTEIN MEDICAL CENTER PHILADELPHIA PA ALLEGHENY GENERAL HOSPITAL PITTSBURGH PA ANN & ROBERT H. LURIE CHILDREN S HOSPITAL OF CHICAGO CHICAGO IL BANNER GOOD SAMARITAN PHOENIX AZ BAPTIST HEALTH MEDICAL CENTER LITTLE ROCK AR BAPTIST MEMORIAL HOSPITAL - MEMPHIS MEMPHIS TN BARNES-JEWISH HOSPITAL ST. LOUIS MO BAYLOR UNIVERSITY MEDICAL CENTER DALLAS TX BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA BRYANLGH MEDICAL CENTER LINCOLN NE CALIFORNIA PACIFIC MEDICAL CENTER SAN FRANCISCO CA CARILION ROANOKE MEMORIAL HOSPITAL ROANOKE VA CAROLINAS MEDICAL CENTER CHARLOTTE NC CEDARS SINAI MEDICAL CENTER LOS ANGELES CA CHILDREN'S HEALTHCARE OF ATLANTA ATLANTA GA CHILDREN'S HOSPITAL BOSTON BOSTON MA CHILDREN'S HOSPITAL OF PITTSBURGH PITTSBURGH PA CHILDREN'S HOSPITAL OF WISCONSIN MILWAUKEE WI CHILDREN'S MEDICAL CENTER DALLAS TX CHRISTIANA CARE HEALTH SYSTEM NEWARK DE CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER CINCINNATI OH CLEVELAND CLINIC CLEVELAND OH COLUMBIA PRESBYTERIAN - CHILDREN'S HOSPITAL OF NEW YORK NEW YORK NY COLUMBIA UNIVERSITY MEDICAL CENTER-NY PRESBYTERIAN NEW YORK NY DUKE UNIVERSITY MEDICAL CENTER DURHAM NC EDWARD HOSPITAL NAPERVILLE IL EMORY UNIVERSITY HOSPITAL ATLANTA GA FLORIDA HOSPITAL ORLANDO FL FROEDTERT & THE MEDICAL COLLEGE OF WISCONSIN MILWAUKEE WI GEISINGER CLINIC DANVILLE PA HACKENSACK UNIVERSITY MEDICAL CENTER HACKENSACK NJ HAHNEMANN UNIVERSITY HOSPITAL PHILADELPHIA PA HARTFORD HOSPITAL HARTFORD CT HENRY FORD HOSPITAL DETROIT MI HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA PHILADELPHIA PA INLAND NORTHWEST THORACIC ORGAN TRANSPLANT PROGRAM - SACRED HEART MEDICAL CENTER Page 4 of 27 SPOKANE INOVA FAIRFAX HOSPITAL FALLS CHURCH VA INTEGRIS BAPTIST MEDICAL CENTER OKLAHOMA CITY OK INTERMOUNTAIN HEART INSTITUTE-ARTIFICIAL HEART PROGRAM MURRAY UT JACKSON MEMORIAL HEALTH SYSTEM/UNIVERSITY OF MIAMI MIAMI FL JEWISH HOSPITAL LOUISVILLE KY WA
5 Page 5 of 27 # HHSN C HOSPITAL NAME CITY STATE KAISER SUNNYSIDE MEDICAL CENTER CLACKAMAS OR LANCASTER GENERAL HOSPITAL LANCASTER PA LANKENAU HOSPITAL WYNNEWOOD PA LEHIGH VALLEY HEALTH NETWORK ALLENTOWN PA LOMA LINDA UNIVERSITY MEDICAL CENTER & CHILDREN'S HOSPITAL LOMA LINDA CA LOYOLA UNIVERSITY MEDICAL CENTER MAYWOOD IL LUTHERAN HOSPITAL OF INDIANA FORT WAYNE IN MAIMONIDES MEDICAL CENTER BROOKLYN NY MASSACHUSETTS GENERAL HOSPITAL BOSTON MA MAYO CLINIC HOSPITAL PHOENIX AZ MAYO CLINIC JACKSONVILLE JACKSONVILLE FL MAYO CLINIC ROCHESTER MN ROCHESTER MN MEDICAL CITY DALLAS HOSPITAL DALLAS TX MEDICAL UNIVERSITY OF SOUTH CAROLINA CHARLESTON SC MEDICAL UNIVERSITY OF SOUTH CAROLINA MEDICAL CENTER CHARLESTON SC MEMORIAL HERMANN TEXAS MEDICAL CENTER HOUSTON TX METHODIST HOSPITAL INDIANPOLIS IN METHODIST SPECIALTY AND TRANSPLANT HOSPITAL SAN ANTONIO TX MID AMERICA HEART INSTITUTE OF SAINT LUKE'S HOSPITAL KANSAS CITY MO MONTEFIORE MEDICAL CENTER BRONX NY MORRISTOWN MEMORIAL HOSPITAL - ATLANTIC HEALTH MORRISTOWN NJ MOUNT SINAI MEDICAL NEW YORK NY MULTICARE HEALTH SYSTEMS TACOMA WA NEMOURS/A.I. DUPONT HOSPITAL FOR CHILDREN WILMINGTON DE NEW YORK UNIVERSITY MEDICAL CENTER NEW YORK NY NEWARK BETH ISRAEL MEDICAL CENTER NEWARK NJ NORTH CAROLINA BAPTIST HOSPITAL WINSTON SALEM NC NORTHWESTERN MEMORIAL HOSPITAL CHICAGO IL OCHSNER MEDICAL CENTER NEW ORLEANS LA OREGON HEALTH & SCIENCE UNIVERSITY PORTLAND OR OSF ST FRANCIS MEDICAL CENTER PEORIA IL PALMETTO HEALTH RICHLAND COLUMBIA SC PENN PRESBYTERIAN MEDICAL CENTER PHILADELPHIA PA PENN STATE MILTON S. HERSHEY MEDICAL CENTER HERSHEY PA PIEDMONT HOSPITAL ATLANTA GA PROVIDENCE ST. VINCENT MEDICAL CENTER PORTLAND OR ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL NEW BRUNSWICK NJ RUSH UNIVERSITY MEDICAL CENTER CHICAGO IL SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC. ATLANTA GA SAINT THOMAS HOSPITAL NASHVILLE TN SCOTT & WHITE HOSPITAL TEMPLE TX SCRIPPS MEMORIAL HOSPITAL LA JOLLA LA JOLLA CA SEATTLE CHILDREN'S HOSPITAL SEATTLE WA SENTARA NORFOLK GENERAL HOSPITAL NORFOLK VA SETON MEDICAL CENTER - AUSTIN AUSTIN TX SHANDS AT THE UNIVERSITY OF FLORIDA GAINESVILLE FL SHARP MEMORIAL HOSPITAL SAN DIEGO CA SPECTRUM HEALTH HOSPITALS GRAND RAPIDS MI ST MARY'S HOSPITAL RICHMOND VA ST PAUL'S HOSPITAL VANCOUVER BC
6 Page 6 of 27 # HHSN C HOSPITAL NAME CITY STATE ST PETERS HOSPITAL ALBANY NY ST. LOUIS CHILDREN'S HOSPITAL ST. LOUIS MO ST. LUKE'S EPISCOPAL HOSPITAL / TEXAS HEART INSTITUTE HOUSTON TX ST. LUKE'S MEDICAL CENTER MILWAUKEE WI ST. VINCENT HOSPITAL AND HEALTH CARE CENTER INDIANAPOLIS IN STANFORD UNIVERSITY MEDICAL CENTER STANFORD CA STONY BROOK UNIVERSITY MEDICAL CENTER STONY BROOK NY SUTTER MEMORIAL HOSPITAL SACRAMENTO CA TAMPA GENERAL HOSPITAL TAMPA FL TEMPLE UNIVERSITY HOSPITAL PHILADELPHIA PA TEXAS CHILDREN'S HOSPITAL HOUSTON TX THE CHILDREN'S HOSPITAL OF PHILADELPHIA PHILADELPHIA PA THE CHILDRENS HOSPITAL DENVER CO THE CHRIST HOSPITAL CINCINNATI OH THE HEART HOSPITAL BAYLOR PLANO PLANO TX THE INDIANA HEART HOSPITAL INDIANAPOLIS IN THE JOHNS HOPKINS HOSPITAL BALTIMORE MD THE MEDICAL CENTER OF CENTRAL GEORGIA MACON GA THE METHODIST HOSPITAL HOUSTON TX THE OHIO STATE UNIVERSITY MEDICAL CENTER COLUMBUS OH THE UNIVERSITY OF TOLEDO TOLEDO OH THOMAS JEFFERSON UNIVERSITY PHILADELPHIA PA TORONTO GENERAL HOSPITAL TORONTO ON TUFTS MEDICAL CENTER BOSTON MA TULANE MEDICAL CENTER NEW ORLEANS LA UC HEALTH UNIVERSITY HOSPITAL CINCINNATI OH UCLA MEDICAL CENTER LOS ANGELES CA UNIVERSITY HOSPITALS CASE MEDICAL CENTER CLEVELAND OH UNIVERSITY OF ALABAMA AT BIRMINGHAM HOSPITAL BIRMINGHAM AL UNIVERSITY OF ARIZONA MEDICAL CENTER TUCSON AZ UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER (UCDMC) SACRAMENTO CA UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO CA UNIVERSITY OF CALIFORNIA, SAN DIEGO MEDICAL CENTER SAN DIEGO CA UNIVERSITY OF CHICAGO HOSPITALS CHICAGO IL UNIVERSITY OF COLORADO HOSPITAL AURORA CO UNIVERSITY OF IOWA HOSPITALS AND CLINICS IOWA CITY IA UNIVERSITY OF KENTUCKY CHANDLER MEDICAL CENTER LEXINGTON KY UNIVERSITY OF MARYLAND MEDICAL CENTER BALTIMORE MD UNIVERSITY OF MICHIGAN HEALTH SYSTEMS ANN ARBOR MI UNIVERSITY OF MINNESOTA MEDICAL CENTER-FAIRVIEW MINNEAPOLIS MN UNIVERSITY OF NEBRASKA MEDICAL CENTER OMAHA NE UNIVERSITY OF NORTH CAROLINA HOSPITALS CHAPEL HILL NC UNIVERSITY OF PITTSBURGH MEDICAL CENTER PITTSBUGH PA UNIVERSITY OF ROCHESTER MEDICAL CENTER (STRONG MEMORIAL HOSPITAL) ROCHESTER NY UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON TX UNIVERSITY OF UTAH HOSPITAL SALT LAKE CITY UT UNIVERSITY OF VIRGINIA HEALTH SYSTEM CHARLOTTESVILLE VA UNIVERSITY OF WASHINGTON MEDICAL CENTER SEATTLE WA UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS MADISON WI USC UNIVERSITY HOSPITAL LOS ANGELES CA
7 HOSPITAL NAME CITY STATE UT SOUTHWESTERN MEDICAL CENTER DALLAS TX VANDERBILT UNIVERSITY MEDICAL CENTER - VANDERBILT HEART AND VASCULAR INSTITUTE NASHVILLE TN VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM RICHMOND VA WASHINGTON HOSPITAL CENTER WASHINGTON DC WEILL CORNELL MEDICAL CENTER/NEW YORK PRESBYTERIAN MEDICAL CENTER NEW YORK NY WESTCHESTER MEDICAL CENTER VALHALLA NY YALE-NEW HAVEN HOSPITAL NEW HAVEN CT YORK HOSPITAL YORK PA Page 7 of 27
8 Exhibit 3: Patient Demographics by Implant Period - Patients 65 Years Old and Older The following tables present demographic characteristics for patients at the time of their primary implant (June 23, 2006 to March 31, 2013). Gender IMPLANT DATE PERIOD GENDER < (Jan-Mar) n % n % n % n % Female % % % % Male % % % % % % % % Race RACE IMPLANT DATE PERIOD < (Jan-Mar) n % n % n % n % African American % % % % Other, Unknown, Undisclosed % % % % White % % % % % % % % Age Category IMPLANT DATE PERIOD AGE GROUP (yr) < (Jan-Mar) n % n % n % n % % % % % % % % % % % % Page 8 of 27
9 Exhibit 4: Implants by Year by Device Strategy - Patients 65 Years Old and Older Page 9 of 27
10 Exhibit 5: Implants per Year by Device Type - Patients 65 Years Old and Older Number of Implants by Device Type and Implant Date Period IMPLANT DATE PERIOD DEVICE TYPE < (Jan-Mar) n % n % n % n % LVAD % % % % BiVAD % % % % TAH % % % % % % % Page 10 of 27
11 Exhibit 6: Patient Profile at Time of Implant by Implant Period - Patients 65 Years Old and Older Patient profile status provides a general clinical description of the patients at the time of implantation. PATIENT PROFILE AT TIME OF IMPLANT IMPLANT DATE PERIOD < (Jan-Mar) n % n % n % n % 1 Critical Cardio Shock % % % % 2 Progressive Decline % % % % 3 Stable but Inotrope dependent % % % % 4 Resting Symptoms % % % % 5 Exertion intolerant % % % % 6 Exertion limited % % % % 7 Advanced NYHA Class % % % % % % % % 1 Critical cardiogenic shock describes a patient who is 'crashing and burning', in which a patient has life-threatening hypotension and rapdily escalating inotropic pressor support. 2 Progressive decline describes a patient who has been demonstrated 'dependent' on inotropic support but nonetheless shows signs of continuing deterioration. 3 Stable but inotrope dependent: describes a patient who is clinically stable on mild-moderate doses of intravenous inotropes. 4 Resting symptoms describes a patient who is at home on oral therapy but frequently has symptoms of congestion at rest or with ADL. 5 Exertion Intolerant describes a patient who is comfortable at rest but unable to engage in any activity, living predominantly within the house or household. 6 Exertion Limited also describes a patient who is comfortable at rest without evidence of fluid overload, but who is able to do some mild activity. 7 Advanced NYHA Class 3 describes a patient who is clinically stable with a reasonable level of comfortable activity, despite history of previous decompensation that is not recent. Page 11 of 27
12 Exhibit 7: Device Strategy at Time of Implant by Implant Period - Patients 65 Years Old and Older Device strategy is determined in conjunction with the heart failure cardiologist and surgeon at the time of the implant. DEVICE STRATEGY AT TIME OF IMPLANT IMPLANT DATE PERIOD < (Jan-Mar) n % n % n % n % BTT - Listed % % % % BTT - Likely % % % % BTT - Moderate % % % % BTT - Unlikely % % % % Destination Therapy % % % % Bridge to Recovery % % % % Rescue Therapy % % % % Other % % % % % % % 1. Bridge to Transplant (BTT) Listed - patient already listed for transplant or listed within 24 hours before device implantation. 2. Bridge to Transplant (BTT) Likely - patient in whom the transplant evaluation has not been completed, but no contra-indications are anticipated, or in whom a current contra-indication is anticipated to resolve rapidly. 3. Bridge to Transplant (BTT) Moderate - patient in whom the transplant evaluation has not been completed, but with some potential concerns that might prevent eligibility. 4. Bridge to Transplant (BTT) Unlikely - patient in whom major concerns that might prevent eligibility have already been identified. 5. Destination Therapy - the patient is definitely not eligible for transplant. 6. Bridge to Recovery (BTR) - use of a durable device to allow recovery from chronic cardiac failure (at least 3 months in duration). 7. Rescue Therapy - use of a durable device to support resolution from an acute event without major previous cardiac dysfunction. 8. Other. Page 12 of 27
13 Exhibit 8: Patient Profile by Device Strategy at Time of Implant - Patients 65 Years Old and Older The following tables present patient profile status by the device strategy for different time periods. Overall PATIENT PROFILE STATUS OVERALL Pre-Implant Device Strategy BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy n % n % n % n % n % n % n % n % n % 1 Critical Cardio Shock % % % % % % % % % 2 Progressive Decline % % % % % % % % 3 Stable but Inotrope dependent % % % % % % % 4 Resting Symptoms % % % % % % % % 5 Exertion intolerant % % % % % % 6 Exertion limited % % % % % % 7 Advanced NYHA Class % % % % % % % % % % % % % Other IMPLANT DATE PERIOD=< 2010 PATIENT PROFILE STATUS OVERALL Pre-Implant Device Strategy BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy n % n % n % n % n % n % n % n % 1 Critical Cardio Shock % % % % % % % % 2 Progressive Decline % % % % % % 3 Stable but Inotrope dependent % % % % % % % 4 Resting Symptoms % % % % % % 5 Exertion intolerant % % % % % 6 Exertion limited % % % % 7 Advanced NYHA Class % % % % % % % % % % % Page 13 of 27
14 IMPLANT DATE PERIOD= # HHSN C PATIENT PROFILE STATUS OVERALL Pre-Implant Device Strategy BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy Other n % n % n % n % n % n % n % n % n % 1 Critical Cardio Shock % % % % % % % % 2 Progressive Decline % % % % % % % % 3 Stable but Inotrope dependent % % % % % % % 4 Resting Symptoms % % % % % % % 5 Exertion intolerant % % % % % 6 Exertion limited % % % % % % 7 Advanced NYHA Class % % % % % % % % % % % IMPLANT DATE PERIOD= (Jan-Mar) PATIENT PROFILE STATUS OVERALL Pre-Implant Device Strategy BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy Other n % n % n % n % n % n % n % n % n % 1 Critical Cardio Shock % % % % % % % % % 2 Progressive Decline % % % % % % % 3 Stable but Inotrope dependent % % % % % % 4 Resting Symptoms % % % % % % % 5 Exertion intolerant % % % % % % 6 Exertion limited % % % % % % 7 Advanced NYHA Class % % % % % % % % % % % %
15 Exhibit 9: Patient Status by Device Strategy at Implant - Patients 65 Years Old and Older The following tables present patient status as of March 31, 2013 by the device strategy for different time periods. Patient status is defined as the first of the following events: Alive (device in place) - patients that were alive at the end of this follow-up period Transplant - patients that have received a transplant during this follow-up period Recovery: patients that were explanted due to recovery at or before the end of this follow-up period Dead: patients who died during this follow-up period. Overall PRE-IMPLANT DEVICE STRATEGY Patient Status (March 31, 2013) 1. Alive (device in place) 2. Transplant 3. Recovery 4. Dead N N N N N BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy Other IMPLANT DATE PERIOD=< 2010 PRE-IMPLANT DEVICE STRATEGY Patient Status (March 31, 2013) 1. Alive (device in place) 2. Transplant 3. Recovery 4. Dead N N N N N BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy Page 15 of 27
16 IMPLANT DATE PERIOD= # HHSN C PRE-IMPLANT DEVICE STRATEGY Patient Status (March 31, 2013) 1. Alive (device in place) 2. Transplant 3. Recovery 4. Dead N N N N N BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy Other IMPLANT DATE PERIOD= (Jan-Mar) PRE-IMPLANT DEVICE STRATEGY Patient Status (March 31, 2013) 1. Alive (device in place) 2. Transplant 3. Recovery 4. Dead N N N N N BTT - Listed BTT - Likely BTT - Moderate BTT - Unlikely Destination Therapy Bridge to Recovery Rescue Therapy Other Page 16 of 27
17 Exhibit 10: Primary Cause of Death - Patients 65 Years Old and Older PRIMARY CAUSE OF DEATH IMPLANT DATE PERIOD < (Jan-Mar) n % n % n % n % Circulatory: Arterial Non-CNS Thromboembolism % % % % Circulatory: CHF % % % % Circulatory: Cardiac Arrhythmia % % % % Circulatory: End Stage Cardiomyopathy % % % % Circulatory: Heart Disease % % % Circulatory: Hemolysis % % % Circulatory: Ischemic Cardiomyopathy % % % % Circulatory: Major Bleeding % % % % Circulatory: Myocardial Infarction % % % % Circulatory: Other, Specify % % % % Circulatory: Pericardial Fluid Collection % % % Circulatory: Right Heart Failure % % % % Circulatory: Sudden Unexplained Death % % % % Device Malfunction % % % % Digestive: Fluid/Electrolyte Disorder % % % Digestive: GI Disorder % % % Digestive: Hepatic Dysfunction % % % % Digestive: Pancreatitis % % Digestive: Renal Dysfunction % % % Major Infection % % % % Multisystem Organ Failure % % % % Nervous System: Neurological Dysfunction % % % % Other % % % % Other: Cancer % % % % Other: Trauma/accident, specify % % % Psychiatric Episode/Suicide % % % Respiratory: Pulmonary: Other, specify % % % Respiratory: Respiratory Failure % % % % Unknown v % % % Withdrawal of Support, specify % % % % % % % % Note: 3 patients have a missing primary cause of death. * Certain pre-relaunch categories are no longer supported as of the v3.0 Launch (May 2012). Page 17 of 27
18 Exhibit 11: Kaplan-Meier Survival for INTERMACS OVERALL - Patients 65 Years Old and Older Number of Patients at Risk Month INTERMACS Overall Page 18 of 27
19 Exhibit 12: Kaplan-Meier Survival by Flow Type and Device - Patients 65 Years Old and Older Number of Patients at Risk Flow Type and Device Month Continuous - LVAD Continuous - BiVAD Pulsatile - LVAD Pulsatile - BiVAD Pulsatile - TAH Page 19 of 27
20 Exhibit 13: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Implant Era - Patients 65 Years Old and Older Number of Patients at Risk Implant Era Month < (Jan-Mar) Page 20 of 27
21 Exhibit 14: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Pre-Implant Device Strategy - Patients 65 Years Old and Older Bridge to Transplant (BTT) includes: BTT-listed, BTT-likely, BTT-moderately likely, and BTT-unlikely. Number of Patients at Risk Pre-Implant Device Strategy Month Bridge to Transplant Destination Therapy Page 21 of 27
22 Exhibit 15: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Pre-Implant Patient Profile - Patients 65 Years Old and Older Number of Patients at Risk Pre-Implant Patient Profile Month Level 1 - Critical Cardiogenic Shock Level 2 - Progressive Decline Level 3 - Stable but Inotrope Dependent Level 4 - Resting Symptoms Levels 5,6,7 - All Others Page 22 of 27
23 Exhibit 16: Kaplan-Meier Survival for Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) by Device Type - Patients 65 Years Old and Older Number of Patients at Risk Device Type Month LVAD BiVAD Page 23 of 27
24 Exhibit 17: Competing Outcomes for Continuous Flow LVADs (without RVAD implant at time of LVAD operation) - Patients 65 Years Old and Older Number of Patients at Risk Month Page 24 of 27
25 Exhibit 18: Competing Outcomes for Continuous Flow LVADs (with RVAD implant at time of LVAD operation) - Patients 65 Years Old and Older Number of Patients at Risk Month Page 25 of 27
26 Exhibit 19: Adverse Event Rates for Patients Receiving a Primary Prospective Implant - Continuous Flow LVADs (with or without RVAD implant at time of LVAD operation) - Patients 65 Years Old and Older The following table summarizes adverse events in patients receiving primary prospective implants between June 23, 2006 and March 31, Event count is the number of episodes observed for each event type allowing multiple episodes per patient. Patient count is the number of patients experiencing at least one episode of a particular event type. Patient percentage is the percent of patients experiencing a specific event type. Early and late event counts are the number of episodes observed either within three months post-implant or after three months post-implant, respectively. Event rates are calculated by dividing the number of episodes observed for each event type during a period by the total amount of follow-up time the patients were observed during the period. The total follow-up time for the early period was patient months and the total follow-up time for the late period was patient months. All rates are reported in episodes per 100 patient months. Adverse Event Type Arterial Non-CNS Thromboembolism Event Count (n=12499) Patient Count (n=2128) Patient Percentage (%) Early Event Count (n) Early Event Rate (per 100 pt mo) Late Event Count (n) Late Event Rate (per 100 pt mo) % Bleeding % Cardiac Arrythmia % Device Malfunction % Hemolysis % Hepatic Dysfunction % Hypertension % Infection % Myocardial Infarction % Neurological Dysfunction % Other Serious Adverse Event % Pericardial Drainage % Psychiatric Episode % Rehospitalization % Renal Dysfunction % Respiratory Failure % Right Heart Failure % Venous Thromboembolism % Wound Dehiscence % Page 26 of 27
27 Exhibit 20: Compliance # HHSN C Site compliance is determined by the percentage of all follow-up forms that are due during this reporting period that have been completed. Follow-up forms for primary devices are included. Only sites that have at least 10 follow-up forms expected are included. INTERMACS has defined required compliance as 90%. Page 27 of 27
INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2013 1st Quarter Implant and event dates: June 23, 2006 to March 31, 2013 Prepared by: The Data
More informationINTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2012 4th Quarter Implant and event dates: June 23, 2006 to December 31, 2012 Prepared by: The Data
More informationQuarterly Statistical Report
01/04/2008 Page 1 of 26 INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report Implant dates: March 1, 2006 November 30, 2007 January 4, 2008 Prepared
More informationIntermacs. Quarterly Statistical Report. Interagency Registry for Mechanically Assisted Circulatory Support
1 Alfred M 14 69 112.5 Intermacs Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2016 Q2 Implant and event dates: June 23, 2006 to June 30, 2016 09/26/2016
More informationINTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
Alfred M 14 69 112.5 INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2013 3rd Quarter Implant and event dates: June 23, 2006 to September 30, 2013
More informationINTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
Alfred M 14 69 112.5 INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2013 4th Quarter Implant and event dates: June 23, 2006 to December 31, 2013
More informationInteragency Registry for Mechanically Assisted Circulatory Support. Quarterly Statistical Report
1 #HHSN268201100025C Intermacs Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2017 Q3 Implant and event dates: June 23, 2006 to September 30, 2017 12/18/2017
More informationIntermacs Interagency Registry for Mechanically Assisted Circulatory Support
Alfred M 14 69 112.5 Intermacs Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2014 1st Quarter Implant and event dates: June 23, 2006 to March 31, 2014
More informationNo Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)
Units Used In Transplants/Infusions No Other Company Discloses Higher Transplant Survival Rate Family Banking Provides Exclusive Access To Emerging Treatments With Your Own Cells 175 85% Type 1 Diabetes
More informationVolunteering in Oklahoma City, OK
6/17/2010 Oklahoma City Profile - Volunteering in information on volunteering and civic engagement Volunteering in Oklahoma City, OK Statistics for this area were collected within the Oklahoma City Metropolitan
More information2010 International Nanny Association Salary and Benefits Survey Information in this report is based on the year About Survey Respondents
2010 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2009 Five hundred and eighty-five (585) in-home child care providers responded to this survey.
More informationHIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview
HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview Prepared by The Henry J. Kaiser Family Foundation for Southern States Summit
More information2018 National Oncologists Workforce Study OCTOBER 2018
2018 National Oncologists Workforce Study OCTOBER 2018 Introduction Providers have long cautioned that the U.S. healthcare system is facing imminent physician shortages across many different specialties.
More information"The Most Challenging Places to Live with Asthma"
"The Most Challenging Places to Live with Asthma" The Asthma Capitals is an annual research project of the Asthma and Allergy Foundation of America (AAFA) to identify "the most challenging places to live
More informationPedimacs. Quarterly Statistical Report. Pediatric Registry for Mechanically Assisted Circulatory Support
1 #HHSN268201100025C Alfred M 14 69 112.5 Pedimacs Pediatric Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2017 2nd Quarter Implant and event dates: September 19,
More informationAlfred M Pediatric Registry for Mechanically Assisted Circulatory Support
1 #HHSN268201100025C Alfred M 14 69 112.5 Pedimacs Pediatric Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2017 3rd Quarter Implant and event dates: September 19,
More informationState Cd. PG1 Inst Name. Madigan Army Med Ctr
Specialty Inst City Inst City Specialty Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology/ UC San Francisco-CA Critical Care FRANCISCO CA C Walter
More informationC/PG2 Specialty Desc. C/PG2 Inst Name. Emory Univ SOM-GA. Child Neurology. Massachuset ts Gen Hosp North Shore Med Ctr/Salem Hosp-MA Orange Park
Inst City e e Emory Univ SOM-GA Anesthesiology ATLANTA GA A Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology UC San Francisco-CA Anesthesiology SAN
More informationProgr am Code Specialty. Preliminary Institution. Emory Univ SOM-GA. Child Neurology
City State Emory Univ SOM-GA Anesthesiology ATLANTA GA A Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology UC San Francisco-CA Anesthesiology SAN FRANCISCO
More informationSPRINT SCHEDULE NO. 11 1st Revised Page Originating Locations for Business Communications Services
1st Revised Page 1 9. SERVICE AREAS AND RATE STEP TABLES 1. Service Locations 1. Originating Locations for Business Communications Services Sprint Clarity, Sprint Premiere, Real Solutions, Business Sense
More informationChapter Two Incidence & prevalence
Chapter Two Incidence & prevalence Science is the observation of things possible, whether present or past. Prescience is the knowledge of things which may come to pass, though but slowly. LEONARDO da Vinci
More informationCAPE FEAR VALLEY PHYSICIAN REFERRAL DIRECTORY
CAPE FEAR VALLEY PHYSICIAN REFERRAL DIRECTORY 2 0 0 6-2 0 0 7 Orthopaedics Christopher J. Barnes, MD Ohio State University College of Medicine, Columbus, OH Duke University Medical Center, Durham, NC Southern
More informationNational & International Lectures
2005-2008 National & International Lectures 6/24/05 ECFS Crete, Greece Mucoid Psuedomonas aeruginosa Infection, Antibiotic Resistance, and Lung Disease Progression in Children with Cystic Fibrosis 9/30/05
More informationThe Clinical Evaluation of the Medtronic AVE Driver Coronary Stent System
The Clinical Evaluation of the Medtronic AVE Driver Coronary Stent System A prospective, multicenter, non randomized study to evaluate the safety and efficacy of the Medtronic AVE Driver Coronary Stent
More informationWalk. Give. To help them live. November 23
PROJECT 13 PARTNERSHIP: St. Jude Children s Research Hospital 2013 Give thanks. Walk. Toolkit Walk. Give. To help them live. November 23 Delta Sigma Theta Sorority, Inc. is proud to continue our support
More informationFifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients
http://www.jhltonline.org SPECIAL FEATURE Fifth INTERMACS annual report: Risk factor analysis from more than 6, mechanical circulatory support patients James K. Kirklin, MD, a David C. Naftel, PhD, a Robert
More informationSASI Analysis of Funds Distributed in the United States By the Centers for Disease Control and Prevention (CDC) Pursuant to PS
SASI Analysis of Funds Distributed in the United States By the Centers for Disease Control and Prevention (CDC) Pursuant to PS17-1704 1 April 13, 2017 INTRODUCTION In the Summer of 2016, the Centers for
More information*All Local Monthlies Data releases are scheduled from 9:00pm - 11:00pm for the date shown on the schedule
JUNE 2017 Local Monthlies Release Schedule Market Name Sequence *All Local Monthlies Data releases are scheduled from 9:00pm - 11:00pm for the date shown on the schedule Market Name Market Type Local Monthlies*
More information% $0 $ % $1,954,710 $177, % $0 $ % $0 $ % $118,444 $59, Mississippi
ATTACHMENT A Palmetto GBA Hospice Cap Overpayments by State As of May 3, 26 Item State Total % completed Total O/P Average O/P # Code State Providers Completed With O/P with O/P Amount Amount Alabama 4
More informationDr. Brian Gray 2011 Lecture Schedule
Dr. Brian Gray 2011 Lecture Schedule Jan. 4 New York, NY New York University School of Dentistry Jan.5 USA Connect Live Webinar, Case Jan. 28 Boston, MA Yankee Dental Conference Invisalign Certification-
More informationBOTCHED ABORTION REPORTS
BOTCHED ABORTION REPORTS Following is a list of apparently botched abortions at abortion clinics. Unless otherwise noted (self admission = self admission to hospital), all required transportation to a
More informationDistal Pancreatectomy with Celiac Axis Resection: What Are the Added Risks?
Distal Pancreatectomy with Celiac Axis Resection: What Are the Added Risks? Joal D. Beane, MD a, Michael G. House, MD a, Susan C. Pitt, MD c, E. Molly Kilbane a, Bruce L. Hall c, Abishek Parmar d, Taylor.
More informationUS clinical trial update on the Gore Excluder iliac branch endoprosthesis (IBE)
US clinical trial update on the Gore Excluder iliac branch endoprosthesis (IBE) Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Maimonides Aortic Center Maimonides Medical Center
More information2014 OREGON STATE FOOTBALL MEDIA GUIDE ALL-TIME SERIES RECORDS ALL-TIME SERIES RECORDS OVERTIME HISTORY. #GoBeavs
ALL-TIME SERIES RECORDS 2014 OREGON STATE FOOTBALL MEDIA GUIDE ALL-TIME SERIES RECORDS OPPONENT TOTAL H A N LAST Akron......................... 1-0 1-0 0-0 0-0 1987 Albany Athletic Club.......... 1-0 1-0
More informationSeventh INTERMACS annual report: 15,000 patients and counting
http://www.jhltonline.org INTERMACS ANNUAL REPORT Seventh INTERMACS annual report: 15,000 patients and counting James K. Kirklin, MD, a David C. Naftel, PhD, a Francis D. Pagani, MD, PhD, b Robert L. Kormos,
More informationThe National Cancer Institute Cancer Centers Program. The Cancer Centers Program of the National Cancer Institute (NCI) supports major
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s The National Cancer Institute
More informationAAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well
AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well mthree TrEATMENT MODALITIES 7 ž 21 ATLAS OF ESRD IN THE
More informationHow do Readmissions Impact Survival among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS
How do Readmissions Impact Survival among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS Rey P. Vivo, MD 1 ; Selim R. Krim, MD 2 ; Jerry D. Estep, MD 3 ; Wissam
More informationVocational Rehabilitation Funding for a Power Wheelchair with Power Adjustable Seat Height:
Vocational Rehabilitation Funding for a Power Wheelchair with Power Adjustable Seat Height: The Americans with Disabilities Act (ADA) was signed into law on July 26, 1990. It is a wide-ranging law intended
More informationDo you have myelofibrosis?
Do you have myelofibrosis? Learn more about a clinical study. What Is a Clinical Study? A clinical study is a way to evaluate a drug in people with a certain illness. Some clinical studies (or clinical
More informationClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: September 30, ClinicalTrials.gov ID: NCT
ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: September 30, 2013 ClinicalTrials.gov ID: NCT00758043 Study Identification Unique Protocol ID: VX08-950-111 Brief
More informationPredicting Major Outcomes after MCSD Implant. Risk Factors for Death, Transplant, and Recovery. James Kirklin, MD David Naftel, PhD
Predicting Major Outcomes after MCSD Implant Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD 1 I have no financial disclosures (I am the Principle Investigator for
More informationDisclosures. Dr. Hall is a paid consultant to the American College of Surgeons (ACS) as Associate Director of ACS-NSQIP
Does Routine Drainage of the Operative Bed following Elective Distal Pancreatectomy reduce Complications? An Analysis of the ACS-NSQIP Pancreatectomy Demonstration Project Stephen W. Behrman, MD 1, Ben
More informationU.S. Apartment Markets Outlook
Market Advisory Services U.S. Apartment Markets Outlook Recent surge in absorption lays foundation for better performance ahead 1 Year-Year Change in 20-34 Employment (000) 2000 2001 2002 2003 2004 2005
More informationZhiwei Zhang, Ph.D. National Opinion Research Center
Drug and Alcohol Use and Related Matters Among Arrestees 2003 Zhiwei Zhang, Ph.D. National Opinion Research Center Acknowledgement This publication was developed for the National Institute of Justice (NIJ),
More informationThe PROACT Trial: valve choice has changed
The PROACT Trial: valve choice has changed Marc W. Gerdisch, MD On behalf of the PROACT Investigators; Chief Cardiovascular and Thoracic Surgery Co-director Franciscan Heart Valve Center Cardiac Surgery
More informationIBM ServicePac Warranty Service Upgrade (WSU)
IBM Maintenance Services ServicePac for Warranty and Maintenance Options IBM ServicePac Warranty Service Upgrade (WSU) Supported Products April 26, 2011 IBM ServicePac Warranty Service Upgrade Post-warranty
More information2003 National Immunization Survey Public-Use Data File
SECTION 1. ID, WEIGHT AND FLAG VARIABLES Section 1 Variable Name SEQNUMC Label UNIQUE CHILD IDENTIFIER Frequency of Missing/Non-missing Values All Data 30930 21310 NON-MISSING CHARACTER STRING 000011 MINIMUM
More informationRadiation Therapy Staffing and Workplace Survey 2016
Radiation Therapy Staffing and Workplace Survey 2016 2016 ASRT. All rights reserved. Reproduction in any form is forbidden without written permission from publisher. TABLE OF CONTENTS Executive Summary...
More informationBiology / Biological Science. Anatomy & Physiology II. Chemistry II Physics I. Chemistry I. Chemistry Physics. Biology II.
& I & II Science I I II I II Exercise Adventist U of Hlth Sci 1 1 1 1 1 1 1 1 2 1 Alabama State U 1 1 1 1 1 1 1 1 3 1 1 1 1 Alvernia U 1 1 1 1 1 1 1 1 1 1 1 American International C 1 1 1 1 1 1 1 1 1 Andrews
More informationRyan White Program Appropriations
Ryan White Program Appropriations Program FY 2011Final 1 FY 2012 Final 4 Coalition FY 2013 CAEAR Request President s FY 2013 Budget Request Part A $672.5m 2 (-$5.4m) $671.3m (-$1.2m) $789.5m (+118.2m)
More informationExhibit 1. Change in State Health System Performance by Indicator
Exhibit 1. Change in State Health System Performance by Indicator Indicator (arranged by number of states with improvement within dimension) Access and Affordability 0 Children ages 0 18 uninsured At-risk
More informationRegional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry
Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry Selim Krim, MD 1 ; Rey Vivo, MD 2 ; Patrick Campbell, MD 1 ; Jerry Estep, MD 3
More informationSmokeless Tobacco Pricing Strategies and Policies
Smokeless Tobacco Pricing Strategies and Policies Frank J. Chaloupka, University of Illinois at Chicago 8 th National Summit on Smokeless and Spit Tobacco Albuquerque, New Mexico, April 20, 2016 Overview
More informationEvan M. Gwilliam DC MBA BS CPC CCPC QCC CPC-I MCS-P CPMA CMHP
Evan M. Gwilliam DC MBA BS CPC CCPC QCC CPC-I MCS-P CPMA CMHP 360-904-0205 801-692-7278 X117 DrG@ChiroCode.com 62 E 300 N Spanish Fork, UT 84660 Experienced physician and certified insurance coder and
More information2015 Lecture Schedule. Jan Phoenix, AZ AlignTech Faculty Conclave Feb 7 Boca Raton, Invisalign Pankey Study Club
2015 Lecture Schedule Jan. 16-17 Phoenix, AZ AlignTech Faculty Conclave Feb 7 Boca Raton, Invisalign Pankey Study Club Feb 20 Austin, TX Invisalign Fundamentals Mar 3 Washington, DC Renaissance Study Club
More informationTHE 2016 DENTAL MEETINGS AND EXHIBITS CALENDAR
HEADLINE 2016 DENTAL MEETINGS AND EXHIBITS CALENDAR The 151st Midwinter Meeting: Three Days of Dental Excellence Chicago Dental Society Chicago, Illinois February 25 27 cds.org/mwm ADA 2016 Annual Meeting
More informationVanderbilt Heart and Vascular Institute 2013 Comprehensive Advanced Heart Failure Summit
Vanderbilt Heart and Vascular Institute 2013 Comprehensive Advanced Heart Failure Summit Friday, August 9, 2013 7:00 AM Registration/Breakfast 7:55 AM Welcome and Opening Remarks Simon Maltais, M.D., Ph.D.,
More informationConcomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis
Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis April 11, 2014 Jason O. Robertson, M.D., M.S.; David C. Naftel, Ph.D., Sunil
More informationWhat has INTERMACS Taught Us about Patient Outcomes with Durable MCS? James K. Kirklin, MD
What has INTERMACS Taught Us about Patient Outcomes with Durable MCS? James K. Kirklin, MD Disclosure: I am Director of the Data Coordinating Center for the INTERMACS project and receive support through
More informationNational List of Equipment Distribution Programs
National List of Equipment Distribution Programs ALABAMA Alabama Telecommunications Access Program (ATAP) 205-328-3989 (Voice/TTY) http://www.alabamarelay.com/atap.html ALASKA *Alaska TEDP 3330 Arctic
More informationHow to mend a broken heart: transplantation or LVAD?
SCDU DI CARDIOCHIRURGIA Università degli Studi di Torino Ospedale S. Giovanni Battista Direttore: Prof. Mauro Rinaldi How to mend a broken heart: transplantation or LVAD? Massimo Boffini Mauro Rinaldi
More informationPayee State Title / Description Program Date
Janssen Therapeutics, Division of Janssen Products, LP, Certified and Non-Certified Grants Report AFIYA Center, Inc. Dallas TX Title / Description Program Date (USD) Date City Living Out Loud (LOL): With
More informationOverview of the States Pesticide Registration Process AAPCO Laboratory Committee
Overview of the States Pesticide Registration Process AAPCO Laboratory Committee Feb 16 th, 2011 Ana Cristina Rodriguez Manager, State Registration/Regulatory Affairs DuPont Crop Protection March 6, 2017
More informationFOCUS Initiative. Arun Skaria FOCUS Regional Lead, New Jersey Associate Director Government Affairs
Initiative Arun Skaria Regional Lead, New Jersey Associate Director Government Affairs About On the... F O C U S rontlines f ommunities in the nited tates Supports CDC Recommendations for Screening and
More informationHEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM
HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM A New Milestone in LVAD Therapy HeartMate 3 Left Ventricular Assist Device Introducing the new HEARTMATE 3 LVAD WITH FULL MAGLEV FLOW TECHNOLOGY HeartMate 3 LVAD
More informationPredicting Outcomes in LVAD Recipients
Predicting Outcomes in LVAD Recipients Sean P. Pinney, MD Director, Advanced Heart Failure & Cardiac Transplantation Professor of Medicine, Cardiology Icahn School of Medicine at Mount Sinai New York,
More informationWomen s health status is one of the strongest determinants of how women use the health care system. The
Women s health status is one of the strongest determinants of how women use the health care system. The poorer their health, the more women need and benefit from high-quality, appropriate care. Overall,
More informationDear Speaker Ryan, Minority Leader Pelosi, Chairman Frelinghuysen, and Ranking Member Lowey:
February 23, 2018 Dear Speaker Ryan, Minority Leader Pelosi, Chairman Frelinghuysen, and Ranking Member Lowey: On behalf of the undersigned organizations we write to urge you to include an increase of
More informationDates & Locations - Spring 2019
Dates & Locations - Spring 2019 Arizona Seminar Date Time Price Location Facility Phone Parking Info Phoenix, AZ 35 New Dentrix Features Yo u Should Be Using 26 Apr 9am 12pm $79 Phoenix, AZ Dentrix Solutions
More informationHow Can Electronic Health Records Help Practice Quality and Efficiency?
How Can Electronic Health Records Help Practice Quality and Efficiency? Michele C. Lim, MD Professor Of Ophthalmology Vice Chair and Medical Director UC Davis Eye Center I have no financial disclosures
More informationCurriculum Vitae. Carter Craig Crouch, M.D. OFFICE: 7401 S. Main Phone: Houston, Texas
Curriculum Vitae NAME: Carter Craig Crouch, M.D. OFFICE: 7401 S. Main Phone: 713-799-2300 Houston, Texas EDUCATION: High School - Alvin High School, Alvin Texas Graduated in 1968 with Honors College -
More informationDouble- and Single-Lung Transplantation: An Analysis of Twenty Years of OPTN/UNOS Registry Data
1 CHAPTER 1 Double- and Single-Lung Transplantation: An Analysis of Twenty Years of OPT/UOS Registry Data Junchao Cai Terasaki Foundation Laboratory, Los Angeles, CA, USA The number of lung transplants
More informationPoisoning Web Links. ASPSA-Animal Poison Control Center
Poisoning Web Links POISON CONTROL CENTERS: American Association of Poison Control Centers http://www.aapcc.org/ ASPSA-Animal Poison Control Center http://www.aspca.org/site/pageserver?pagename=apcc Alabama
More informationType of Program Hospital Program City State. Type of Program Specialty. Specialty Hospital Program City State
Specialty Hospital Program City State Type of Program Hospital Program City State Type of Program Specialty Anesthesiology B I Deaconess Med Ctr- Anesthesiology BOSTON C Brigham & Womens Hosp- Anesthesiology
More informationSETPOINT2 Quarterly Newsletter July 5, 2017
SETPOINT2 Quarterly Newsletter July 5, 2017 We are very pleased to introduce the SETPOINT2 newsletter. SETPOINT2 is a research study involving people with stroke and respiratory failure (breathing problems)
More informationReduced Anticoagulation After Mechanical Valve Replacement: Interim Results from the PROACT Randomized FDA IDE Trial
Reduced Anticoagulation After Mechanical Valve Replacement: Interim Results from the PROACT Randomized FDA IDE Trial John D. Puskas, MD, FACS, FACC Emory University National Principal Investigator On Behalf
More informationObjectives Primary Objective: Secondary Objectives For T4 a, b, c tumors:
Z1031 A randomized phase III trial comparing 16 to 18 weeks of neoadjuvant exemestane (25mg daily), letrozole (2.5mg), or anastrozole (1mg) in postmenopausal women with clinical stage II and III estrogen
More informationEarly Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study
Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have
More informationBreast Imaging Fellowships in the United States: Who, What, and Where?
Women s Imaging Perspective Baxi et al. Breast Imaging Fellowships Women s Imaging Perspective FOCUS ON: Shrujal S. Baxi 1 Laura Liberman 2 Carol Lee 2 Elena B. Elkin 1 Baxi SS, Liberman L, Lee C, Elkin
More information2012 Medicaid and Partnership Chart
2012 Medicaid and Chart or Alabama $525,000.00 $4,800.00 Minimum: 25,000.00 Alaska $525,000.00 Depends on area of state; Minimum: $113,640 $10,000 in Anchorage $1,656 Minimum:$1838.75 Maximum:$2,841 Minimum:
More informationASAIO 64 th Annual Conference Turning Ideas Into Solutions Through Innovation June 13 16, 2018 Washington, DC
Program Outline 2018 December 14, 2017 ASAIO 64 th Annual Conference Turning Ideas Into Solutions Through Innovation June 13 16, 2018 Washington, DC www.asaio.com 8:30am 4:30pm 7 th Annual Pediatric Medical
More informationReady Today for the. Brian Kelly, MD Aetna National Medical Director. Future of Health Care
Ready Today for the Brian Kelly, MD Aetna National Medical Director Future of Health Care Aetna s Leadership Strategy Quality Creating Value Health Literacy Transparency Evidence-based Engaging Consumers,
More information2012 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2011
2012 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2011 Six hundred seventy-three (673) in-home child care providers responded to this survey.
More informationTranscatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis Suboptimal for
Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis Suboptimal for Surgery: One-Year Results from the Evolut R US Pivotal Study
More informationISHLT 35 th Annual Meeting and Scientific Sessions th April, 2015, Nice, France
HeartWare HVAD for the Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation: Results of the ENDURANCE Destination Therapy Trial FD Pagani 1, CA Milano 2, AJ Tatooles
More informationSupplement to Achieving a State of Healthy Weight
Composition of Ratings of Practices 0 (Highest to Lowest) Fully Met Partially Met Not Addressed Contradicted IB: Feed infants on cue IA: No cow s milk < yr IB: Hold infant to feed IC: Plan solid introduction
More informationHEARTMATE 3 LVAD WITH FULL MAGLEV FLOW TECHNOLOGY THEIR FUTURE STARTS WITH YOU
HEARTMATE 3 WITH FULL MAGLEV FLOW TECHNOLOGY THEIR FUTURE STARTS WITH YOU HEARTMATE 3 with Full MagLev Flow Technology HEARTMATE 3 DELIVERS UNPRECEDENTED * SURVIVAL AND SAFETY OUTCOMES **1 LANDMARK SURVIVAL
More informationDiet Charts: The Keeper's Tool and Aide
Diet Charts: The Keeper's Tool and Aide John T. Wright The Baltimore Zoo, Baltimore, Maryland For most institutions, whether public or private, conservation of endangered species is a high priority. Conservationist
More informationASAIO 64 th Annual Conference Turning Ideas In To Solutions Through Innovation June 13 16, 2018 Washington, DC
Program Outline 2018 December 7, 2017 ASAIO 64 th Annual Conference Turning Ideas In To Solutions Through Innovation June 13 16, 2018 Washington, DC www.asaio.com 8:30am 4:30pm 7 th Annual Pediatric Medical
More informationIn State Answer Rate 01/01/2017 to 6/30/2017
In State 01/01/2017 to 6/30/2017 In-State by Originating State 1/1/2017 to 6/30/2017 Eastern Time State Initiated ed AK 2,156 1,434 AL 8,739 6,014 AR 4,688 0 AZ 9,777 9,010 CA 82,224 69,410 CO 11,525 10,379
More informationHealth Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin. The WHI Investigators
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin The WHI Investigators 1 Background: WHI Hormone Program Design YES N= 10,739 Conjugated equine estrogen
More informationReport to Congressional Defense Committees
Report to Congressional Defense Committees The Department of Defense Comprehensive Autism Care Demonstration Quarterly Report to Congress Second Quarter, Fiscal Year 2017 In Response to: Senate Report
More informationAbout the Symposium. About the NAGC. Past Locations
Past Locations 1997 - Oberlin, Ohio 1998 - Cincinnati, Ohio About the Symposium The National Alliance for Grieving Children (NAGC) Symposium is the longest running and most comprehensive national conference
More informationImproving Access to Oral Health Care for Vulnerable and Underserved Populations
Improving Access to Oral Health Care for Vulnerable and Underserved Populations Report of the Committee on Oral Health Access to Services Shelly Gehshan Director, Pew Children s Dental Campaign Committee
More informationRadiation Therapy Staffing and Workplace Survey 2018
Radiation Therapy Staffing and Workplace Survey 2018 2018 ASRT. All rights reserved. Reproduction in any form is forbidden without written permission from publisher. Table of Contents Radiation Therapy
More informationBALTIMORE CITY HIV/AIDS EPIDEMIOLOGICAL PROFILE Second Quarter Data reported through June 30, 2008
BALTIMORE CITY HIV/AIDS EPIDEMIOLOGICAL PROFILE Second Quarter 2008 - Data reported through June 30, 2008 AIDS Administration Maryland Department of Health and Mental Hygiene www.dhmh.state.md.us/aids/
More informationSEC Professionals Group
SEC Professionals Group 2018 Media Kit The preeminent group for financial reporting professionals learning from each other and sharing best practices. WHO WE ARE The SEC Professionals Group is a community
More informationCURRICULUM VITAE HERBERT S. GATES, III, M.D., P.A. 681 Goodlette Road North Suite 220 Naples, Florida
CURRICULUM VITAE HERBERT S. GATES, III, M.D., P.A. 681 Goodlette Road North Suite 220 Naples, Florida 34102 239-263-4511 UNDERGRADUATE EDUCATION: Boston University School for the Arts, Boston Massachusetts
More information2011 Heroin Domestic Monitor Program
U.S. Department of Justice Drug Enforcement Administration D R U G E N F O R C E M E N T A D M I N I S T R A T I O N 2011 Heroin Domestic Monitor Program March 2013 DEA-NWW-RPT-005-13 Drug Enforcement
More information